The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of IGM Biosciences Inc (NASDAQ: IGMS) was $10.19 for the day, down -1.16% from the previous closing price of $10.31. In other words, the price has decreased by -$1.16 from its previous closing price. On the day, 75483.0 shares were traded. IGMS stock price reached its highest trading level at $10.83 during the session, while it also had its lowest trading level at $10.115.
Ratios:
Our analysis of IGMS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.06 and its Current Ratio is at 7.06. In the meantime, Its Debt-to-Equity ratio is 0.32 whereas as Long-Term Debt/Eq ratio is at 0.27.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on February 09, 2024, Upgraded its rating to Outperform and sets its target price to $21 from $9 previously.
On December 15, 2023, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $8.
H.C. Wainwright Downgraded its Buy to Neutral on December 07, 2023, whereas the target price for the stock was revised from $11 to $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 25 ’24 when Hambleton Julie sold 15,132 shares for $14.00 per share. The transaction valued at 211,848 led to the insider holds 2,000 shares of the business.
Weber Steven sold 495 shares of IGMS for $3,750 on Jun 14 ’24. The PRINCIPAL ACCOUNTING OFFICER now owns 26,012 shares after completing the transaction at $7.58 per share. On Jun 14 ’24, another insider, Takimoto Chris H, who serves as the CHIEF MEDICAL OFFICER of the company, sold 1,570 shares for $7.58 each. As a result, the insider received 11,893 and left with 95,818 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IGMS now has a Market Capitalization of 604457536 and an Enterprise Value of 387449248. For the stock, the TTM Price-to-Sale (P/S) ratio is 207.72 while its Price-to-Book (P/B) ratio in mrq is 4.93. Its current Enterprise Value per Revenue stands at 133.098 whereas that against EBITDA is -1.712.
Stock Price History:
Over the past 52 weeks, IGMS has reached a high of $17.70, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is 10.77%, while the 200-Day Moving Average is calculated to be 8.64%.
Shares Statistics:
IGMS traded an average of 300.70K shares per day over the past three months and 156090 shares per day over the past ten days. A total of 33.18M shares are outstanding, with a floating share count of 20.77M. Insiders hold about 64.98% of the company’s shares, while institutions hold 37.40% stake in the company. Shares short for IGMS as of 1723680000 were 5781970 with a Short Ratio of 19.23, compared to 1721001600 on 5699405. Therefore, it implies a Short% of Shares Outstanding of 5781970 and a Short% of Float of 38.379999999999995.
